| CYSB2400272 | 人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2024-10-15 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
| CYSB2400273 | 人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2024-10-15 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
| CYSB2400271 | 人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2024-10-15 | | Beijing Kawin Technology Share-Holding Co Ltd | | | view |
| CYSB2400240 | 人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2024-09-13 | | Anhui Anke Biotechnology (Group) Co Ltd | | | view |
| CYSB2400238 | 人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2024-09-13 | | Anhui Anke Biotechnology (Group) Co Ltd | | | view |
| CYSB2400239 | 人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2024-09-13 | | Anhui Anke Biotechnology (Group) Co Ltd | | | view |
| CYSB2400241 | 人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2024-09-13 | | Anhui Anke Biotechnology (Group) Co Ltd | | | view |
| CYSB2400242 | 人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2024-09-13 | | Anhui Anke Biotechnology (Group) Co Ltd | | | view |
| CYSB2400243 | 人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2024-09-13 | | Anhui Anke Biotechnology (Group) Co Ltd | | | view |
| CYSB2300129 | 人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2023-07-12 | | Anhui Anke Biotechnology (Group) Co Ltd | | | view |
| CXSS2300019 | 人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products(3.4) | New Drug Application | 2023-04-19 | | Changchun Lnstitute of Biological Products Co Ltd | | | view |
| CXSS2000038 | 重组人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products(13) | New Drug Application | 2020-07-04 | 长春生物制品研究所有限责任公司 | Changchun Lnstitute of Biological Products Co Ltd | Certificate Issued | 2021-08-04 | view |
| CYSB2000118 | 重组人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2020-05-29 | 安徽安科生物工程（集团）股份有限公司 | Anhui Anke Biotechnology (Group) Co Ltd | In Review | 2020-05-28 | view |
| CYSB2000117 | 重组人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2020-05-29 | 安徽安科生物工程（集团）股份有限公司 | Anhui Anke Biotechnology (Group) Co Ltd | In Review | 2020-05-28 | view |
| CYSB2000116 | 重组人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2020-05-29 | 安徽安科生物工程（集团）股份有限公司 | Anhui Anke Biotechnology (Group) Co Ltd | In Review | 2020-05-28 | view |
| CYSB2000115 | 重组人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2020-05-29 | 安徽安科生物工程（集团）股份有限公司 | Anhui Anke Biotechnology (Group) Co Ltd | In Review | 2020-05-28 | view |
| CYSB1800229 | 重组人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2018-10-29 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2020-10-27 | view |
| CYSB1800228 | 重组人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2018-10-29 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2020-10-27 | view |
| CYSB1800230 | 重组人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products | Supplementary Application | 2018-10-29 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2020-10-27 | view |
| CXSL1700150 | 重组人干扰素α2b注射液 | Recombinant Human Interferon α2b | Injection | Biological Products(13) | New Drug Application | 2018-03-30 | 长春生物制品研究所有限责任公司 | Changchun Lnstitute of Biological Products Co Ltd | Certificate Issued | 2018-07-06 | view |
